Please assess the completion status of the following clinical trial:

Trial Title: Growth Hormone Treatment in Children With Hypophosphatemic Rickets

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* clinical, biochemical and genetic diagnosis of XLH~* height SDS \< 2~* at least two years of treatment with oral phosphate and calcitriol~Exclusion Criteria:~* uncontrolled rickets (ALP\>600 IU)~* growth hormone deficiency~* hyperparathyroidism, nephrocalcinosis, renal insufficiency~* associated disease~* previous treatment with growth hormone

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- norditropine simplex (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).